High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$64.5M
$64,514,005
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-03-09
$34,736
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-09 | $34,736 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-09
$58,270
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-09 | $58,270 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-17
$11,505
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-17 | $11,505 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-17
$6,438
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-17 | $6,438 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-13
$113,857
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-13 | $113,857 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.6%
2026-02-13
$175,100
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.6%
|
2026-02-13 | $175,100 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-13
$36,118
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-13 | $36,118 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-13
$96,776
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-13 | $96,776 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-13
$59,366
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-13 | $59,366 | M | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-12
$6,857
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-12 | $6,857 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-12
$15,442
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-12 | $15,442 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -10.3%
2026-02-12
$168,635
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -10.3%
|
2026-02-12 | $168,635 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-09
$34,736
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-09 | $34,736 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-09
$65,586
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-09 | $65,586 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-20
$6,423
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-20 | $6,423 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-20
$13,354
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-20 | $13,354 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -18.4%
2026-01-14
$370,645
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -18.4%
|
2026-01-14 | $370,645 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-13
$36,128
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-13 | $36,128 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.1%
2026-01-13
$252,470
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.1%
|
2026-01-13 | $252,470 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-13
$59,380
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-13 | $59,380 | M | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-12 | $293,707 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-12 | $235,932 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-12
$6,856
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-12 | $6,856 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-12
$205,143
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-12 | $205,143 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
10b5-1 SellΔOwn -55.5%
2026-01-12
$345,723
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -55.5%
|
2026-01-12 | $345,723 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-09
$34,720
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-09 | $34,720 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-09
$72,196
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-09 | $72,196 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Other
|
2025-11-21 | $13,004 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Slingsby Brian Taylor
• Director
Discretionary SellΔOwn -11.2%
2025-11-20
$43,350,000MEGA
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -11.2%
|
2025-11-20 | $43,350,000MEGA | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Karydas Daphne
• Director
Discretionary Sell
2025-11-13
$226,446
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-13 | $226,446 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-13 | $27,968 | M | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-13 | $126,900 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary Sell
2025-11-13
$592,503
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-13 | $592,503 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-13 | $153,000 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Karydas Daphne
• Director
Discretionary SellΔOwn -67.4%
2025-11-13
$463,351
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -67.4%
|
2025-11-13 | $463,351 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-12 | $70,717 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary Sell
2025-11-12
$91,386
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-12 | $91,386 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary SellΔOwn -72.1%
2025-11-12
$232,500
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -72.1%
|
2025-11-12 | $232,500 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-11 | $153,000 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
Discretionary SellΔOwn -10.4%
2025-11-11
$539,479
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary SellΔOwn -10.4%
|
2025-11-11 | $539,479 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $359,258 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $180,183 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $382,046 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
Discretionary SellΔOwn -42.7%
2025-11-11
$1,786,588Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary SellΔOwn -42.7%
|
2025-11-11 | $1,786,588Large | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
Discretionary SellΔOwn -62.8%
2025-11-11
$1,533,977Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary SellΔOwn -62.8%
|
2025-11-11 | $1,533,977Large | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $66,623 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary SellΔOwn -66.7%
2025-11-11
$424,298
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -66.7%
|
2025-11-11 | $424,298 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary Sell
2025-11-11
$235,408
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-11 | $235,408 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Other
|
2025-11-11 | $209,579 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary Sell
2025-11-11
$1,540,212Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $1,540,212Large | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary SellΔOwn -14.5%
2025-11-11
$5,145,956Whale
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary SellΔOwn -14.5%
|
2025-11-11 | $5,145,956Whale | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary Sell
2025-11-11
$1,320,165Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $1,320,165Large | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $173,984 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $374,947 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $533,235 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $472,932 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $42,630 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Other
|
2025-11-11 | $102,105 | M | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Other
|
2025-11-11 | $628,126 | M | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Other
|
2025-11-11 | $550,624 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.7%
2025-10-15
$445,982
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.7%
|
2025-10-15 | $445,982 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $66,782 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $577,544 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-13 | $143,333 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-13 | $308,651 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -10.0%
2025-09-15
$333,946
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -10.0%
|
2025-09-15 | $333,946 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2025-09-15
$75,320
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-09-15 | $75,320 | S | Form 4 |